Trial intelligence / Profile preview

Filgrastim in Bone Marrow Donors (ASCT0631D)

NCT01149096Phase 3Completed

Sponsor
Children's Oncology Group
Start
Jun 2010
Primary completion
Dec 2011
Modality
Cytokines & Interferons
Countries
1
01

Overview

A Phase 3 trial of filgrastim, sponsored by Children's Oncology Group. Started Jun 2010; status: completed.

02

Drugs

filgrastim

Beyond the preview

Go deeper on NCT01149096.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01149096.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call